NCT01554956View on ClinicalTrials.gov

Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 22, 2013

Primary Completion Date

April 25, 2014

Study Completion Date

December 4, 2020

Conditions
Ligneous Conjunctivitis
Interventions
BIOLOGICAL

Human Plasminogen

Eye Drops

Trial Locations (3)

46260

Indiana Hemophilia & Thrombosis Center, Indianapolis

Unknown

Meyer Children's Hospital, Florence

AOU Padova, Padua

All Listed Sponsors
lead

Kedrion S.p.A.

INDUSTRY

NCT01554956 - Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients | Biotech Hunter | Biotech Hunter